Home › Funds › Citadel Advisors › ELEV
Citadel Advisors position in ELEV
ELEVATION ONCOLOGY INC
Latest position (Q2 2025)405.20K sh
Reported value held$148.75K
Portfolio Weight0.00%
First reportedQ4 2021
Last changeAdd
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 21.86K | $132.00K | New |
| Q2 2023 | 838.59K | $1.27M | New |
| Q3 2023 | 840.20K | $556.72K | Hold |
| Q4 2023 | 591.48K | $317.63K | Reduce |
| Q1 2024 | 1.57M | $8.06M | Add |
| Q2 2024 | 42.91K | $115.86K | Reduce |
| Q3 2024 | 28.30K | $16.98K | Reduce |
| Q4 2024 | 269.64K | $151.70K | Add |
| Q1 2025 | 69.00K | $17.88K | Reduce |
| Q2 2025 | 405.20K | $148.75K | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.